Coeptis Therapeutics Holdings, Inc. 8-K

What Happened
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) announced via an 8‑K and a press release dated April 7, 2026 that Nasdaq has approved — subject to customary conditions and the closing of the proposed merger with Z Squared Inc. — the listing of the post‑merger company’s common stock on the Nasdaq Global Market under the ticker symbol "ZSQR." The Form 8‑K was filed April 8, 2026 and includes the press release as an exhibit.

Key Details

• Approval: Nasdaq has approved the listing of the post‑merger company’s common stock, subject to customary conditions and the merger closing.
• Ticker: The post‑merger company would trade under the symbol ZSQR on the Nasdaq Global Market.
• Disclosure: The announcement was made in a press release dated April 7, 2026 and included in the Form 8‑K filed April 8, 2026.

Why It Matters
A Nasdaq Global Market listing for the combined company is a notable corporate milestone: it may improve visibility and market access for the post‑merger entity and is a key procedural step toward completing the transaction. The approval is conditional — the listing only takes effect if the merger with Z Squared Inc. closes and customary Nasdaq conditions are satisfied — so investors should monitor further filings for merger progress, closing confirmations, and any related financial disclosures.